Development of the Thermal Beam Loss Monitors of the SPIRAL2 Control System

http://accelconf.web.cern.ch/AccelConf/ICALEPCS2013/papers/moppc043.pdfInternational audienceThe Spiral2 linear accelerator will drive high intensity beams, up to 5mA, to up to 200kW at linac exit. Such beams can seriously damage and activate the machine ! To prevent from such situation, the Machine Protection System (MPS) has been designed. This system is connected to diagnostics indicating if the beam remains under specific limits. As soon as a diagnostic detects its limit is crossed, it informs the MPS which will in turn take actions that can lead to a beam cut-off in appropriated timing requirements. In this process, the Beam Loss Monitors (BLM) are involved in monitoring prompt radiation generated by beam particles interactions with beam line components and responsible for activation, on one side, and thermal effects, on the other side. BLM system relies mainly on scintillator detectors, NIM electronics and a VME subsystem monitoring the heating of the machine. This subsystem, also called "Thermal BLM", will be integrated in the Spiral2 EPICS environment. For its development, a specific project organization has been setup since the development is subcontracted to Cosylab. This paper focuses on the Thermal BLM controls aspects and describes this development process

Preliminary implementation for the new SPIRAL2 project control system

International audienceThe Spiral2 project consists of a new facility to provide high intensity rare ions beams. It is based on a primary beam driver accelerator (RFQ followed by a superconducting linac) and a rare ion production process delivering the beam either to a low energy experimental area or to the existing Ganil facility. From October this year, one ion source coupled with a first beam line section will be in test; then, the injector (ion and deuteron sources, RFQ) will be tested by the end of 2010 so the whole accelerator should be commissioned by the end of 2011; the first exotic beams being planned one year later. The accelerator control system design results from the collaboration between several institutes and Epics has been chosen as the basic framework. The paper therefore presents the main choices: MVME5500 CPUs, VME I/O boards, VxWorks, Siemens PLCs, Modbus field buses, EDM screens and Java applications, Linux PCs, use of a LabView/Epics gateway... Specific topics are the evaluation of the XAL environment, an Epics design to address the power supplies, an emittance measurement system, the development of a beam profiler interface and the investigation for a triggered acquisition system

The SPIRAL2 control system progress towards the commissioning phase

MOCOAAB03, http://accelconf.web.cern.ch/AccelConf/ICALEPCS2013/papers/mocoaab03.pdfInternational audienceThe commissioning of the first phase of the Spiral2 Radioactive Ion Beams facility at Ganil will soon start, so requiring the control system components to be delivered in time. Yet, parts of the system were validated during preliminary tests performed with ions and deuterons beams at low energy. The control system development results from the collaboration between Ganil, CEA-IRFU, CNRS-IPHC laboratories, using appropriate tools and approach. Based on Epics, the control system follows a classical architecture. At the lowest level, Modbus/TCP protocol is considered as a field bus. Then, equipment are handled by IOCs (soft or VME/VxWorks) with a software standardized interface between IOCs and clients applications on top. This last upper layer consists of Epics standard tools, CSS/BOY user interfaces within the socalled CSSop Spiral2 context suited for operation and, for machine tunings, high level applications implemented by Java programs developed within a Spiral2 framework derived from the open-Xal one. Databases are used for equipment data and alarms archiving, to configure equipment and to manage the machine lattice and beam settings. A global overview of the system is therefore here proposed

A New Precision Measurement of the 7Be(p,gamma)8B Cross section with an Implanted 7Be Target

The 7Be(p,gamma)8B reaction plays a central role in the evaluation of solar neutrino fluxes. We report on a new precision measurement of the cross section of this reaction, following our previous experiment with an implanted 7Be target, a raster scanned beam and the elimination of the backscattering loss. The new measurement incorporates a more abundant 7Be target and a number of improvements in design and procedure. The point at Elab=991 keV was measured several times under varying conditions, yielding a value of S17(Ec.m. =850 keV) = 24.0(5) eV b. Measurements were carried out at lower energies as well. Due to the precise knowledge of the implanted 7Be density profile it was possible to reconstitute both the off- and on resonance parts of the cross section and to obtain from the entire set of measurements an extrapolated value of S17(0)=21.2(7) eV b.Comment: 4 Pages, 3 Figure

A Small but Efficient Collaboration for the Spiral2 Control System Development

http://accelconf.web.cern.ch/AccelConf/ICALEPCS2013/papers/tucobab01.pdfThe Spiral2 radioactive ion beam facility to be commissioned in 2014 at Ganil (Caen) is built within international collaborations. This also concerns the control system development shared by three laboratories: Ganil has to coordinate the control and automated systems work packages, CEA/IRFU is in charge of the "injector" (sources and low energy beam lines) and the LLRF, CNRS/IPHC provides the emittancemeters and a beam diagnostics platform. Besides the technology Epics based, this collaboration, although being handled with a few people, nevertheless requires an appropriate and tight organization to reach the objectives given by the project. This contribution describes how, started in 2006, the collaboration for controls has been managed both from the technological point of view and the organizational one, taking into account not only the previous experience, technical background or skill of each partner, but also their existing working practices and "cultural" approaches. A first feedback comes from successful beam tests carried out at Saclay and Grenoble; a next challenge is the migration to operation, Ganil having to run Spiral2 as the other members are moving to new projects

Astrophysical S factor for the He-4(He-3,gamma)Be-7 reaction at medium energies

3 pags., 1 tab. -- Nuclear Physics in Astrophysics V 3–8 April 2011, Eilat, IsraelThe astrophysical S factor for the He-4(He-3,gamma)Be-7 direct capture reaction plays a major role in the context of solar neutrino flux and primordial Li-7 abundances that demand accurate information on the reaction. We report here our recent cross section measurements using the activation method in the region of E-CM=900-2800 keV, that aim to shed light on the discrepancies in the existing data and lead to a more accurate extrapolation of the S factor

Duration of Treatment for Pseudomonas aeruginosa Bacteremia : a Retrospective Study

Introduction: There is no consensus regarding optimal duration of antibiotic therapy for Pseudomonas aeruginosa bacteremia. We aimed to evaluate the impact of short antibiotic course. Methods: We present a retrospective multicenter study including patients with P. aeruginosa bacteremia during 2009-2015. We evaluated outcomes of patients treated with short (6-10 days) versus long (11-15 days) antibiotic courses. The primary outcome was a composite of 30-day mortality or bacteremia recurrence and/or persistence. Univariate and inverse probability treatment-weighted (IPTW) adjusted multivariate analysis for the primary outcome was performed. To avoid immortal time bias, the landmark method was used. Results: We included 657 patients; 273 received a short antibiotic course and 384 a long course. There was no significant difference in baseline characteristics of patients. The composite primary outcome occurred in 61/384 patients in the long-treatment group (16%) versus 32/273 in the short-treatment group (12%) (p = 0.131). Mortality accounted for 41/384 (11%) versus 25/273 (9%) of cases, respectively. Length of hospital stay was significantly shorter in the short group [median 13 days, interquartile range (IQR) 9-21 days, versus median 15 days, IQR 11-26 days, p = 0.002]. Ten patients in the long group discontinued antibiotic therapy owing to adverse events, compared with none in the short group. On univariate and multivariate analyses, duration of therapy was not associated with the primary outcome. Conclusions: In this retrospective study, 6-10 days of antibiotic course for P. aeruginosa bacteremia were as effective as longer courses in terms of survival and recurrence. Shorter therapy was associated with reduced length of stay and less drug discontinuation

The Spiral2 Control System Progress Towards the Commission Phase

MOCOAAB0